Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome
Clinical trial NCT04400032 · COMPLETED
Trial details
- NCT number
- NCT04400032
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-15
- Primary completion
- 2021-04-22
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.